Debra Hughes, MS

Most Recent Articles by Debra Hughes, MS

OPIAD Management Requires a Multidisciplinary Care Team Approach

By Dec 13, 2016

Despite initial recognition of opioid-induced androgen deficiency (OPIAD) as a possible consequence of opioid use more than four decades ago, few studies have systematically investigated hormonal changes induced by long-term opioid administration.

Biosimilars for Rheumatic Diseases: Safety, Efficacy of Switching Assessed

By Nov 15, 2016

The investigators found switching data for 12 studies in rheumatic diseases.

Clinical Profile for Diagnostic Delay in Psoriatic Arthritis Points to Females, Enthesitis

By Nov 14, 2016

Several recent studies have shown that a delay in diagnosis of PsA leads to a worse outcome.

SOF/VEL/VOX Effective as Retreatment for Non-NS5A DAA Failures

By Nov 14, 2016

Treatment with single tablet sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for 12 weeks "is a highly effective salvage therapy" for patients who did not previously achieve sustained virologic response (SVR) following treatment with non-NS5A inhibitor-containing direct-acting antivirals (DAAs), results from the POLARIS-4 study presented at The Liver Meeting® 2016 have shown.

'MK3' Fixed-Dose Combination Effective in HCV GT 1, 2, and 3

By Nov 14, 2016

A fixed-dose combination of pangenotypic direct-acting antivirals was "highly effective" in treatment-naïve patients with hepatitis C virus (HCV) genotypes (GT) 1, 2, and 3

More Articles by Debra Hughes, MS